END STAGE RENAL DISEASE ON DIALYSIS
Clinical trials for END STAGE RENAL DISEASE ON DIALYSIS explained in plain language.
Never miss a new study
Get alerted when new END STAGE RENAL DISEASE ON DIALYSIS trials appear
Sign up with your email to follow new studies for END STAGE RENAL DISEASE ON DIALYSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Needle vs. scalpel: which dialysis access works best?
Disease control Recruiting nowThis study compares two methods for creating an arteriovenous fistula (AVF) in people with end-stage kidney disease who need dialysis. The newer endovascular method uses a needle through the skin, while the traditional surgical method requires an incision. Researchers will enroll…
Matched conditions: END STAGE RENAL DISEASE ON DIALYSIS
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jul 02, 2026 02:00 UTC
-
New pill could help dialysis patients control dangerous phosphate levels
Disease control Recruiting nowThis study tests a new drug called AP306 in 168 adults on maintenance hemodialysis who have high phosphate levels (hyperphosphatemia). Participants take one of several fixed doses of AP306 or a placebo daily for 8 weeks. The main goal is to see if AP306 safely lowers blood phosph…
Matched conditions: END STAGE RENAL DISEASE ON DIALYSIS
Phase: PHASE2 • Sponsor: R1 Therapeutics • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could a Starch-Based drug clean toxins from dialysis Patients' blood?
Disease control Recruiting nowThis trial tests whether a drug called coated aldehyde oxystarch (Xiqing) can reduce protein-bound uremic toxins in adults with end-stage renal disease who are on dialysis. Participants take the drug three times daily for three months. Researchers measure toxin levels in the bloo…
Matched conditions: END STAGE RENAL DISEASE ON DIALYSIS
Phase: NA • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a diabetes drug boost dialysis efficiency for kidney patients?
Disease control Recruiting nowThis study tests if empagliflozin, a diabetes drug, can reduce sugar absorption during peritoneal dialysis in 30 adults with end-stage kidney disease. Participants will receive either the drug or a placebo in a crossover design, followed by an 8-week open-label phase where everyo…
Matched conditions: END STAGE RENAL DISEASE ON DIALYSIS
Phase: PHASE4 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Simple walk and relax routine tested to fight dialysis fatigue
Symptom relief Recruiting nowThis study tests whether a program that combines gentle walking with progressive muscle relaxation can help reduce the extreme tiredness (fatigue) that many people with end-stage kidney disease feel while on dialysis. Researchers will enroll 40 adults who are on hemodialysis and …
Matched conditions: END STAGE RENAL DISEASE ON DIALYSIS
Phase: NA • Sponsor: University of Illinois at Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
New study peers inside lungs during Clot-Busting procedure
Knowledge-focused Recruiting nowThis study watches what happens to the lungs when doctors use a balloon to clear a clot in a dialysis patient's arm graft. Using a special belt that takes pictures of lung activity, researchers will check if tiny clot pieces briefly affect how air and blood flow in the lungs. Twe…
Matched conditions: END STAGE RENAL DISEASE ON DIALYSIS
Sponsor: First Affiliated Hospital of Wannan Medical College • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC